G.P.14.14 Differences in aberrant expression and splicing of genes involved in Ca2+ metabolism between myotonic dystrophy type 2 (DM2) and type 1 (DM1)
Anna Vihola(University of Helsinki), Ralf Krahe(University of Helsinki), Tiina Suominen(Tampere University), Bjarne Udd(Folkhälsans Forskningscentrum), Shodimu Emmanuel Olufemi(The University of Texas MD Anderson Cancer Center), Linda L. Bachinski(Baylor College of Medicine), O. Raheem(Institute of Genetics), Mario Sirito(Inserm)
Cited by 1
Related Papers
Severe iron deficiency anemia in transgenic mice expressing liver hepcidin
|Proceedings of the National Academy of Sciences|2002|882
Mutations in the Gene for Cardiac Myosin-Binding Protein C and Late-Onset Familial Hypertrophic Cardiomyopathy
|New England Journal of Medicine|1998|759
The myotonic dystrophies: molecular, clinical, and therapeutic challenges
|The Lancet Neurology|2012|487
Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein Titin
|The American Journal of Human Genetics|2002|484